{"text": "while directed at autoimmune inflammation this article has a part on irak4 targeting interleukin 1 receptor activated kinase 4 discusses programs at pfe bayer gild cris rigl bmy genentech roche protacs via gsk and janssen and kymr"}
{"text": "great overview of irak4 mentions combination potential the 4 leading irak4 development programs pfe bayer gild and cris notes rigl has an irak4 in development but structure has not been disclosed links the protac approach in irak4 degradation"}
{"text": "spx component stocks ttm returns no typo 501 505 holdings are positive ttm 4 in red ed biib vtrs amp gild only holding w negative return gt 10 quintile cutoffs q1 140 q2 93 median 75 5 q3 69 q4 41 q5 10 but q5 midpoint 23 crazy markets 1"}
{"text": "gilead s virology drug head to take east coast biotech s ceo post gild alvr via"}
{"text": "how to trade when the price of gilead sciences gild talks people listen click for details"}
{"text": "diana brainard to lead alvr succeeding david hallal who remains executive chair brainard is head of virology at gild"}
